201 related articles for article (PubMed ID: 36388031)
1. Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer.
Huang B; Deng W; Chen P; Mao Q; Chen H; Zhuo Z; Huang Z; Chen K; Huang J; Luo Y
Transl Cancer Res; 2022 Oct; 11(10):3724-3740. PubMed ID: 36388031
[TBL] [Abstract][Full Text] [Related]
2. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
PeerJ; 2024; 12():e16868. PubMed ID: 38313020
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
Zhou Y; Guo Y; Wang Y
IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel ubiquitination related gene signature for patients with breast cancer.
Zheng Y; Lu W; Chen B; Zhao K
Medicine (Baltimore); 2022 Sep; 101(37):e30598. PubMed ID: 36123926
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
9. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
10. Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer.
Zhao K; Zheng Y; Lu W; Chen B
Front Genet; 2022; 13():932027. PubMed ID: 36685836
[No Abstract] [Full Text] [Related]
11. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
14. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
Front Genet; 2021; 12():717319. PubMed ID: 34899826
[No Abstract] [Full Text] [Related]
15. Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer.
Chen G; Dong Y; Shi W; Li L; Zhu W; Xie L; Song X
Transl Cancer Res; 2022 Apr; 11(4):725-735. PubMed ID: 35571667
[TBL] [Abstract][Full Text] [Related]
16. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y
Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681
[TBL] [Abstract][Full Text] [Related]
18. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F
Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856
[No Abstract] [Full Text] [Related]
19. Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.
Xu F; Zou C; Gao Y; Shen J; Liu T; He Q; Li S; Xu S
Front Immunol; 2022; 13():930488. PubMed ID: 36091054
[TBL] [Abstract][Full Text] [Related]
20. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
